Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03921151 · ClinicalTrials.gov registry record · Phase 1
5HT2CR Balance in Brain Connectivity in Cocaine Dependence
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT03921151 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 90 participants.
The verdict
NCT03921151, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
This project will evaluate the role of the 5-HT2CR:5-HT2AR balance in impulsive action and cue reactivity in cocaine-dependent subjects as compared to non-drug using controls.
Interventions
- DRUG Mirtazapine 15 MG Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-05-13 |
| Est. Completion | 2019-01-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03921151
The ClinicalTrials.gov registry entry for NCT03921151 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mirtazapine 15 MG Oral Tablet is the first listed.
NCT03921151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03921151 about?
NCT03921151 is a clinical study titled "5HT2CR Balance in Brain Connectivity in Cocaine Dependence". This project will evaluate the role of the 5-HT2CR:5-HT2AR balance in impulsive action and cue reactivity in cocaine-dependent subjects as compared to non-drug using controls.
What is the current status of trial NCT03921151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2014-05-13. Estimated completion is 2019-01-24.
What interventions are being tested in trial NCT03921151?
The interventions under investigation include: Mirtazapine 15 MG Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03921151?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.